SCHEMBL26019684

SCHEMBL26019684

Cc1ccc(C(F)(F)F)cc1C(=O)C(C)(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.50
TAS2R14 Q9NYV8 1/20 0.47
SORT1 Q99523 3/20 0.45
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
HPGD P15428 2/20 0.43
HSD17B10 Q99714 2/20 0.43
CFTR P13569 1/20 0.42
CNR2 P34972 2/20 0.42
CNR1 P21554 1/20 0.42
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
USP2 O75604 1/20 0.41
CYP2C19 P33261 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
RXFP1 Q9HBX9 1/20 0.40
KCNJ6 P48051 1/20 0.40
KCNJ3 P48549 1/20 0.40
NOTUM Q6P988 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL710431 0.83 TAS2R14 (0.59) CES2TAS2R14SORT1KDM4EALDH1A1
SCHEMBL3925394 0.83 CES2 (0.52) CES2TAS2R14SORT1KDM4EALDH1A1
SCHEMBL15745421 0.81 CES2 (0.50) CES2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL26020665 0.81 CES2 (0.70) CES2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL5323409 0.81 CES2 (0.50) CES2TAS2R14SORT1KDM4EALDH1A1
SCHEMBL477753 0.81 CES2 (0.50) CES2TAS2R14SORT1KDM4EALDH1A1
SCHEMBL9541475 0.80 ALDH1A1 (0.59) CES2SORT1KDM4EALDH1A1HPGD
SCHEMBL1679303 0.80 RXRA (0.49) CES2TAS2R14SORT1KDM4EALDH1A1
SCHEMBL26019646 0.79 CES2 (0.44) CES2ALDH1A1MEN1KMT2ACES1
SCHEMBL3943371 0.79 CFTR (0.64) CES2TAS2R14SORT1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257382-A1 HETEROCYCLIC COMPOUND AND USE THEREOF WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD. (CN) 2023-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257382-A1 HETEROCYCLIC COMPOUND AND USE THEREOF TRPC5, TRPC1, GOT1 CES2 4349/4885TAS2R14 4397/4885SORT1 742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.